​

Day One Biopharmaceuticals (DAWN) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Day One Biopharmaceuticals Revenue Highlights

Latest Revenue (Y)

$158.18M

Latest Revenue (Q)

$39.80M

Main Segment (Y)

Product

Day One Biopharmaceuticals Revenue by Period

Day One Biopharmaceuticals Revenue by Year

DateRevenueChange
2025-12-31$158.18M20.60%
2024-12-31$131.16M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Day One Biopharmaceuticals generated $158.18M in revenue during NA 2025, up 20.60% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Day One Biopharmaceuticals Revenue by Quarter

DateRevenueChange
2025-09-30$39.80M17.36%
2025-06-30$33.91M10.23%
2025-03-31$30.76M5.32%
2024-12-31$29.21M-68.85%
2024-09-30$93.76M1044.54%
2024-06-30$8.19M100.00%
2024-03-31--100.00%
2023-12-31$560.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Day One Biopharmaceuticals generated $39.80M in revenue during Q3 2025, up 17.36% compared to the previous quarter, and up 485.78% compared to the same period a year ago.

Day One Biopharmaceuticals Revenue Breakdown

Day One Biopharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24
Product$155.42M$57.22M
License$2.76M$73.94M

Day One Biopharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product (98.25%), and License (1.75%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
License$884.00K$1.27M$346.00K$258.00K$253.00K$73.69M-
Product$52.83M$38.52M$33.56M$30.50M$28.95M$20.07M$8.19M

Day One Biopharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Product (98.35%), and License (1.65%).

Day One Biopharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ARVNArvinas$262.60M$41.90M
GERNGeron$183.88M$47.23M
DAWNDay One Biopharmaceuticals$158.18M$39.80M
VALNValneva SE$153.70M$32.75M
VIRVir Bio$68.56M$240.00K
RZLTRezolute--
REPLReplimune Group--
ERASErasca--
TYRATyra Biosciences--
AVBPArriVent BioPharma--

DAWN Revenue FAQ

What is Day One Biopharmaceuticals’s yearly revenue?

Day One Biopharmaceuticals's yearly revenue for 2025 was $158.18M, representing an increase of 20.60% compared to 2024. The company's yearly revenue for 2024 was $131.16M, representing an increase of 100.00% compared to 2023. DAWN's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022.

What is Day One Biopharmaceuticals’s quarterly revenue?

Day One Biopharmaceuticals's quarterly revenue for Q3 2025 was $39.8M, a 17.36% increase from the previous quarter (Q2 2025), and a -57.56% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $33.91M, a 10.23% increase from the previous quarter (Q1 2025), and a 313.92% increase year-over-year (Q2 2024). DAWN's quarterly revenue for Q1 2025 was $30.76M, a 5.32% increase from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Day One Biopharmaceuticals’s revenue growth rate?

Day One Biopharmaceuticals's revenue growth rate for the last 3 years (2023-2025) was 0%, and for the last 5 years (2021-2025) was 0%.

What are Day One Biopharmaceuticals’s revenue streams?

Day One Biopharmaceuticals's revenue streams in c 25 are Product, and License. Product generated $155.42M in revenue, accounting 98.25% of the company's total revenue, up 171.63% year-over-year. License generated $2.76M in revenue, accounting 1.75% of the company's total revenue, down -96.27% year-over-year.

What is Day One Biopharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Day One Biopharmaceuticals was Product. This segment made a revenue of $155.42M, representing 98.25% of the company's total revenue.